tiprankstipranks
Evoke Pharma (EVOK)
NASDAQ:EVOK
US Market

Evoke Pharma (EVOK) Income Statement

Compare
466 Followers

Evoke Pharma Income Statement

Last quarter (Q4 2024), Evoke Pharma's total revenue was $3.31M, an increase of 97.40% from the same quarter last year. In Q4, Evoke Pharma's net income was $-1.19M. See Evoke Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.25T$ 5.18M$ 2.51M$ 1.62M$ 23.02K
Gross Profit
$ 10.25T$ 4.98M$ 2.14M$ 1.29M$ -63.69K
Operating Expenses
$ 15.45T$ 12.41M$ 9.92M$ 9.44M$ 12.98M
Depreciation and Amortization
$ 0.00$ 138.60K$ 7.79M$ 8.15M$ 13.05M
EBITDA
$ -5.20T$ -7.29M$ -7.72M$ -8.04M$ -13.04M
Operating Income
$ -5.20T$ -7.43M$ -7.79M$ -8.15M$ -13.05M
Other Income/Expenses
$ -148.06B$ -361.40K$ -437.99K$ -386.31K$ -107.32K
Pretax Income
$ -5.35T$ -7.79M$ -8.22M$ -8.54M$ -13.15M
Net Income
$ -5.35T$ -7.79M$ -8.16M$ -9.03M$ -13.26M
Per Share Metrics
Basic EPS
$ -3.82M$ -27.97$ -31.16$ -40.40$ -74.91
Diluted EPS
$ -3.82M$ -27.97$ -31.16$ -40.40$ -74.91
Weighted Average Shares Outstanding
1.40M 278.59K 261.97K 223.51K 177.03K
Weighted Average Shares Outstanding (Diluted)
1.40M 278.59K 261.97K 223.51K 177.03K
Currency in USD

Evoke Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis